Raffa Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Raffa Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37	Closed	-$6.8K	–	1140
2021 Q2	$6.8K	Hold	37	–	–	﹤0.01%	321
2021 Q1	$5.66K	Buy	37 +5	+16%	+$773	﹤0.01%	381
2020 Q4	$5K	Buy	32 +13	+68%	+$1.67K	﹤0.01%	362
2020 Q3	$2.17K	Hold	19	–	–	﹤0.01%	473
2020 Q2	$2.13K	Hold	19	–	–	﹤0.01%	461
2020 Q1	$1.71K	Hold	19	–	–	﹤0.01%	459
2019 Q4	$2.06K	Hold	19	–	–	﹤0.01%	397
2019 Q3	$1.86K	Buy	+19	New	+$2.14K	﹤0.01%	411
2019 Q2	–	Sell	-19	Closed	-$2.57K	–	1438
2019 Q1	$2.57K	Hold	19	–	–	﹤0.01%	312
2018 Q4	$1.85K	Hold	19	–	–	﹤0.01%	369
2018 Q3	$2.64K	Hold	19	–	–	﹤0.01%	343
2018 Q2	$2.36K	Hold	19	–	–	﹤0.01%	345
2018 Q1	$2.12K	Buy	+19	New	+$2.27K	﹤0.01%	345
2017 Q1	–	Sell	-6	Closed	-$734	–	885
2016 Q4	$734	Hold	6	–	–	﹤0.01%	551
2016 Q3	$735	Hold	6	–	–	﹤0.01%	531
2016 Q2	$701	Hold	6	–	–	﹤0.01%	519
2016 Q1	$835	Hold	6	–	–	﹤0.01%	455
2015 Q4	$1.15K	Hold	6	–	–	﹤0.01%	360
2015 Q3	$938	Hold	6	–	–	﹤0.01%	401
2015 Q2	$1.08K	Hold	6	–	–	﹤0.01%	374
2015 Q1	$1.04K	Hold	6	–	–	﹤0.01%	379
2014 Q4	$1.11K	Hold	6	–	–	﹤0.01%	337
2014 Q3	$995	Buy	+6	New	+$985	﹤0.01%	347
2014 Q1	–	Sell	-6	Closed	-$1.11K	–	756
2013 Q4	$1.11K	Buy	+6	New	+$720	﹤0.01%	337

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Raffa Wealth Management's ALXN Position: Q3 2021 in Review

Raffa Wealth Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 37 shares — an estimated $6.8K sold.

Raffa Wealth Management first reported a position in ALXN in Q4 2013 and held it in 24 quarters. The position peaked at $6.8K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Raffa Wealth Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Raffa Wealth Management sold 37 Alexion Pharmaceuticals shares in Q3 2021, an estimated $6.8K.
Raffa Wealth Management first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 24 quarters.
Raffa Wealth Management's Alexion Pharmaceuticals position peaked at $6.8K in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Raffa Wealth Management's 13F filing for Q3 2021, filed 27 Jul 2026.